Genmab’s Stellar Cancer-Drug Data Fuels Stock’s $10 Billion Week
30. Oktober 2026 um 09:01
It’s been a breakout week for Danish biotech Genmab A/S.
Madrid has turned into a value hub thanks to years of market-beating returns by Francisco García Paramés and his peers.













